State legislators across the country are addressing healthcare costs as a top priority during this legislative session. While making healthcare more affordable is a worthy goal, several bills that have been introduced claiming to lower healthcare costs would instead increase costs, reduce access to prescription drugs, and cause the loss of thousands of jobs. Since […]
Americans are continually worried about the cost of healthcare. There are a plethora of good and bad ideas to make healthcare more affordable, including Most Favored Nation (MFN) price controls, which would import prices for pharmaceuticals from other countries, many of which rely on socialized medicine and government-run healthcare. But price controls in any industry, […]
Congress created the 340B program in 1992 to fix a problem it had created two years earlier when it implemented price controls, or rebates, in the Medicaid drug benefit program. As a condition to participate in Medicaid, pharmaceutical companies must also partake in the 340B program, giving significant discounts of between 20-50 percent, to certain federally-funded […]
The One Big Beautiful Bill Act (OBBBA), which extended and enhanced the 2017 Tax Cuts and Jobs Act, included other significant benefits to taxpayers, like fulfilling the promise President Trump made during the 2024 presidential election campaign to eliminate taxes on Social Security benefits. The OBBBA allows taxpayers aged 65 and over to deduct between […]
Missouri is moving ahead with the process of eliminating the state income tax. In his January 13, 2026, State of the State Address, Governor Mike Kehoe (R) called for the income tax to be eliminated over five years. The process would require the approval of voters in the November 2026 election. On January 28, 2026, […]
The enhanced Affordable Care Act subsidies that were at the center of the October government shutdown were not only made available to people making as much as $500,000 annually but also turned out to be rife with waste, fraud, and abuse. A December 3, 2025, Government Accountability Office (GAO) report revealed that the advanced premium […]
As Americans gather with family and friends to celebrate Thanksgiving, healthcare costs are one of their main concerns. President Trump has made lowering drug prices and increasing domestic biopharmaceutical research and development high priorities in his second term in office. Domestic investment by drug companies has skyrocketed since Eli Lilly was the first company to […]
The United States is the global leader in developing innovative and life-saving cures and treatments thanks to the investments made by pharmaceutical companies in the United States, including the vaccines that helped end the coronavirus pandemic. Vaccines are crucial to the physical and economic health of not just Americans but also people across the rest […]
The 340B Drug Discount Program was given the laudable goal of helping federally funded clinics and public hospitals that serve a large uninsured population cover the cost of drugs and provide discounts to patients. However, like many other well-intended federal programs 340B has gone off the rails due to the lack of clear intent and […]
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]
